Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis

Faina Vikhanskaya, Sara Vignati, Patrizia Beccaglia, Cristina Ottoboni, Patrizia Russo, Maurizio D'Incalci, Massimo Broggini

Research output: Contribution to journalArticlepeer-review

Abstract

Paclitaxel-induced cytotoxicity, cell cycle perturbation, and apoptosis were determined in a human ovarian cancer cell line expressing wt p53 (A2780) and in a subclone (A2780/E6) obtained upon transfection with the product of the E6 gene of the human papilloma virus HPV16. The inactivation of wt p53 in A2780/E6 was verified by measuring the inability of the clone to induce p53 and p21 expression after paclitaxel treatment. The p53-negative clone (A2780/E6) was approximately 50-fold more sensitive to paclitaxel than wt p53-expressing A2780 cells. This increased sensitivity was related to the ability of paclitaxel to induce a strong arrest of cells in the G2/M phase of the cell cycle in A2780/E6 but not in A2780 cells. This different cell cycle arrest was accompanied by increased frequency of paclitaxel-induced p53- independent apoptosis. Initial studies on proteases activation tend to exclude a direct role of ICE and CPP32 in the induction of apoptosis in these cells and show a paclitaxel-dependent increase in FLICE levels, whose biological relevance is however at present not defined.

Original languageEnglish
Pages (from-to)96-101
Number of pages6
JournalExperimental Cell Research
Volume241
Issue number1
DOIs
Publication statusPublished - May 25 1998

ASJC Scopus subject areas

  • Cell Biology

Fingerprint

Dive into the research topics of 'Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis'. Together they form a unique fingerprint.

Cite this